ALX ONCOLOGY HOLDINGS INC (ALXO) Stock Balance Sheet
NASDAQ:ALXO - US00166B1052 - Common Stock
1.02 USD
-0.01 (-0.97%)
0.97 USD
-0.05 (-4.9%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 19.30M | N/A | 22.41M | 48.80M | 363.70M | |||
| Marketable Securities | 60.01M | N/A | 160.33M | 217.40M | N/A | |||
| Receivables | 638.00K | 1.34M | 1.00M | N/A | N/A | |||
| Other Current Assets | 5.30M | 5.26M | 4.92M | 4.80M | 3.40M | |||
| Total Current Assets | 85.26M | 134.00M | 189.00M | 271.00M | 367.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.13M | 9.63M | 11.00M | 9.80M | 3.40M | |||
| Investments And Advances | 4.23M | 3.52M | 35.00M | 16.70M | N/A | |||
| Other Non-Current Assets | 700.00K | 200.00K | 7.58M | 9.00M | 9.80M | |||
| Total Non-Current Assets | 10.06M | 14.00M | 54.00M | 35.50M | 13.20M | |||
| TOTAL ASSETS | 95.32M | 148.00M | 243.00M | 306.50M | 380.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 4.05M | 1.40M | 730.00K | 300.00K | 400.00K | |||
| Accrued Expenses | 9.62M | 12.00M | 26.00M | 19.80M | 11.10M | |||
| Accounts Payable | 4.90M | 4.50M | 8.59M | 8.10M | 3.80M | |||
| Other Current Liabilities | 283.00K | 660.00K | 630.00K | 200.00K | N/A | |||
| Total Current Liabilities | 18.85M | 19.00M | 36.00M | 28.30M | 15.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 8.19M | 11.00M | 11.00M | 9.40M | 300.00K | |||
| Other Non-Current Liabilities | 3.87M | 4.49M | 5.63M | 5.30M | 1.60M | |||
| Total Non-Current Liabilities | 12.06M | 15.00M | 17.00M | 14.70M | 1.80M | |||
| TOTAL LIABILITIES | 30.91M | 34.00M | 53.00M | 43.00M | 17.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -677.83M | -621.00M | -486.00M | -325.50M | -202.00M | |||
| Additional Paid In Capital | 742.15M | 734.00M | 676.00M | 589.70M | 565.00M | |||
| Common Shares | 54.00K | 50.00K | 50.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 36.00K | 280.00K | 260.00K | -800.00K | N/A | |||
| Shares Outstanding | 53.51M | 53.00M | 50.00M | 40.90M | 40.60M | |||
| Tangible Book Value per Share | 1.20 | N/A | 3.80 | 6.44 | 8.94 | |||
| Total Shareholders' Equity | 64.42M | 114.00M | 190.00M | 263.50M | 363.00M | |||
| TOTAL LIABILITIES AND EQUITY | 95.32M | 148.00M | 243.00M | 306.50M | 380.20M | |||
| Statistics | ||||||||
| Debt/Equity | 0.13 | 0.10 | 0.06 | 0.04 | 0.00 | |||
| Current Ratio | 4.52 | 7.05 | 5.25 | 9.58 | 23.99 | |||
| Return On Assets (ROA) | -122.30% | -91.22% | -66.26% | -40.29% | -21.95% | |||
| Return On Equity (ROE) | -180.97% | -118.42% | -84.74% | -46.86% | -22.99% | |||
All data in USD , ROIC based on taxRate of 0.21